Two newer money market ETFs, Texas Capital Government Money Market ETF (MMKT) and JPMorgan 100% U.S. Treasury Securities Money Market ETF (JMMF), provide weekly income distributions, differing from traditional monthly payouts. MMKT invests mainly in government securities and repurchase agreements, offering a 3.77% yield with a 0.20% expense ratio, while JMMF focuses solely on U.S. Treasury securities, yielding 3.75% with a 0.16% expense ratio and potential state and local tax exemptions. These ETFs trade intraday with fluctuating prices, unlike traditional money market mutual funds that maintain a stable $1 NAV. They offer convenience for ETF investors and retirees seeking weekly income but may not suit those preferring stable NAV funds.
The story about MMKT and JMMF money market ETFs is presented with Pluang's Financials-sector data for context. For readers following this sector, as of Oct 14, 2026 19:42 WIB, out of 142 priced US Financial stocks, only 17 rose while 118 fell. Notable movers include WULF at USD 12.58 with a -4.77% change and a typical hold time of 18 days, HUT at USD 79.86 down 4.49% with a 12-day hold, and RKT at USD 10.43 down 3.69%.
Jefferies has maintained a Buy rating on Big Yellow Group despite recent stock declines, citing the company's strong fundamentals including freehold properties and solid cash flows. Activist investor Ancora, holding over 4% of shares, is pushing Big ...
Fastenal reported strong Q3 2026 earnings, beating analyst expectations with EPS of $0.35 and revenue of $2.46 billion. The company saw a 20% rise in net income to $401.6 million and a 15.5% increase in revenue driven by robust manufacturing demand, ...
Remittix announced the public launch of its RTX token on November 24, 2026, marking the end of its presale phase which raised over $32 million from 40,000 participants. The project is testing its PayFi platform, which enables crypto-to-fiat and fiat-...
The global microbiology testing market is projected to grow rapidly at a compound annual growth rate (CAGR) of approximately 9% from 2026 to 2034, reaching a market size of $13.7 billion by 2034. This growth is driven by the rising prevalence of infe...
H.C. Wainwright raised its price target for Alector from $5.00 to $8.00, maintaining a Buy rating due to progress in its neurodegenerative disease pipeline. Alector develops treatments for Alzheimer's and Parkinson's using its Brain Carrier platform ...
